Skip to main content
. 2023 Jul 28;131(7):077010. doi: 10.1289/EHP12215

Table 3.

Associations of air pollutants with risk of enterotomy in individuals with IBD, CD, and UC in the UK Biobank Study, mean follow-up of 12 y.

Air pollutants in quartiles (μg/m3) IBD (n=4,708) CD (n=1,485) UC (n=3,233)
Cases/person-years HR (95% CI)a p-Value HR (95% CI)b p-Valuec Cases/person-years HR (95% CI)b p-Value Cases/person-years HR (95% CI)b p-Value
NOx
 Per IQR (15.6) 1.11 (1.00, 1.23) 0.059 1.10 (0.98, 1.23) 0.091 1.14 (0.98, 1.32) 0.082 1.16 (0.96, 1.40) 0.115
 Q1 (19.7 to<34.8) 70/13,719 Ref Ref 29/4,318 Ref 41/9,503 Ref
 Q2 (34.8 to<42.0) 56/13,758 0.80 (0.56, 1.13) 0.202 0.72 (0.51, 1.03) 0.071 23/4,159 0.76 (0.44, 1.32) 0.324 33/9,651 0.75 (0.42, 1.35) 0.338
 Q3 (42.0 to<50.4) 70/13,541 0.99 (0.71, 1.38) 0.949 0.93 (0.66, 1.29) 0.650 31/4,366 1.03 (0.62, 1.72) 0.911 39/9,212 1.19 (0.69, 2.04) 0.527
 Q4 (50.4–247.5) 69/13,823 0.98 (0.70, 1.37) 0.908 0.93 (0.66, 1.30) 0.660 32/4,108 1.04 (0.62, 1.72) 0.892 37/9,751 1.12 (0.65, 1.94) 0.684
p-Trend 0.791 0.975 0.626 0.353
NO2
 Per IQR (10.4) 1.07 (0.94, 1.23) 0.310 1.06 (0.92, 1.22) 0.431 1.12 (0.91, 1.37) 0.294 1.12 (0.90, 1.40) 0.301
 Q1 (10.0 to<23.0) 65/13,706 Ref Ref 27/4,413 Ref 38/9,379 Ref
 Q2 (23.0 to<27.9) 53/13,767 0.82 (0.57, 1.17) 0.273 0.77 (0.54, 1.11) 0.167 21/4,147 0.78 (0.44, 1.39) 0.404 32/9,683 1.00 (0.55, 1.83) 0.990
 Q3 (27.9 to<33.4) 79/13,691 1.21 (0.87, 1.69) 0.246 1.15 (0.83, 1.60) 0.410 35/4,250 1.25 (0.75, 2.08) 0.384 44/9,476 1.68 (0.98, 2.89) 0.060
 Q4 (33.4–86.6) 68/13,677 1.04 (0.74, 1.46) 0.825 0.99 (0.70, 1.39) 0.947 32/4,142 1.15 (0.68, 1.92) 0.609 36/9,579 1.11 (0.62, 1.99) 0.732
p-Trend 0.358 0.515 0.307 0.357
PM10
 Per IQR (2.3) 1.08 (0.93, 1.24) 0.316 1.07 (0.92, 1.23) 0.388 1.15 (0.93, 1.43) 0.185 0.99 (0.79, 1.26) 0.960
 Q1 (13.7 to<18.0) 56/13,843 Ref Ref 20/4,215 Ref 36/9,688 Ref
 Q2 (18.0 to<19.1) 70/13,824 1.25 (0.88, 1.77) 0.222 1.21 (0.85, 1.72) 0.291 31/4,477 1.56 (0.89, 2.75) 0.122 39/9,415 1.06 (0.61, 1.84) 0.843
 Q3 (19.1 to<20.3) 70/13,650 1.27 (0.89, 1.80) 0.185 1.23 (0.87, 1.75) 0.244 33/4,192 1.57 (0.90, 2.75) 0.114 37/9,490 1.27 (0.74, 2.18) 0.391
 Q4 (20.3–28.6) 69/13,524 1.23 (0.86, 1.75) 0.251 1.20 (0.84, 1.71) 0.310 31/4,068 1.48 (0.84, 2.61) 0.176 38/9,524 0.97 (0.55, 1.71) 0.908
p-Trend 0.275 0.333 0.225 0.919
PM2.5
 Per IQR (1.3) 1.16 (1.01, 1.33) 0.030 1.16 (1.00, 1.34) 0.043 1.24 (1.04, 1.47) 0.017 1.19 (0.95, 1.49) 0.133
 Q1 (8.2 to<9.3) 53/13,900 Ref Ref 21/4,470 Ref 32/9,506 Ref
 Q2 (9.3 to<9.9) 70/13,601 1.35 (0.94, 1.92) 0.102 1.36 (0.95, 1.95) 0.090 28/4,237 1.37 (0.78, 2.42) 0.275 42/9,423 1.63 (0.90, 2.94) 0.105
 Q3 (9.9 to<10.6) 63/13,603 1.21 (0.84, 1.75) 0.297 1.19 (0.82, 1.72) 0.366 23/4,137 1.14 (0.63, 2.07) 0.670 40/9,525 1.56 (0.86, 2.81) 0.142
 Q4 (10.6–20.7) 79/13,737 1.51 (1.07, 2.14) 0.020 1.58 (1.09, 2.28) 0.015 43/4,107 2.09 (1.24, 3.54) 0.006 36/9,663 1.51 (0.83, 2.76) 0.176
p-Trend 0.044 0.040 0.010 0.249

Note: —, no data; BMI, body mass index; CD, Crohn’s disease; CI, confidence interval; HR, hazard ratio; IBD, inflammatory bowel disease; IQR, interquartile range; NO2, nitrogen dioxide; NOx, nitrogen oxides; PM, particulate matter; PM2.5 PM with aerodynamic diameter 2.5μm; PM10, PM with aerodynamic diameter 10μm; Ref, reference; UC, ulcerative colitis.

a

Based on Cox proportional model adjusted for age, sex, ethnicity.

b

Based on Cox proportional model adjusted for age, sex, ethnicity, assessment centers, household income, smoking status, education, BMI, physical activity, healthy diet, alcohol consumption, baseline related surgery history, medication (use of nonsteroidal anti-inflammatory drugs, amino salicylates, corticosteroids, and immunomodulators).

c

p-Value <0.05 was considered statistically significant.